15-66387311-TC-TCC

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_002755.4(MAP2K1):​c.-31dupC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0954 in 1,516,248 control chromosomes in the GnomAD database, including 8,983 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 977 hom., cov: 31)
Exomes 𝑓: 0.095 ( 8006 hom. )

Consequence

MAP2K1
NM_002755.4 5_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.965

Publications

5 publications found
Variant links:
Genes affected
MAP2K1 (HGNC:6840): (mitogen-activated protein kinase kinase 1) The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. [provided by RefSeq, Jul 2008]
MAP2K1 Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen
  • Noonan syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 15-66387311-T-TC is Benign according to our data. Variant chr15-66387311-T-TC is described in ClinVar as [Benign]. Clinvar id is 40710.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAP2K1NM_002755.4 linkc.-31dupC 5_prime_UTR_variant Exon 1 of 11 ENST00000307102.10 NP_002746.1 Q02750-1A4QPA9
MAP2K1XM_017022411.3 linkc.-31dupC 5_prime_UTR_variant Exon 1 of 10 XP_016877900.1 Q02750-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAP2K1ENST00000307102.10 linkc.-31dupC 5_prime_UTR_variant Exon 1 of 11 1 NM_002755.4 ENSP00000302486.5 Q02750-1

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15489
AN:
151718
Hom.:
978
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0940
Gnomad AMI
AF:
0.0463
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.132
Gnomad EAS
AF:
0.337
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0818
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0836
Gnomad OTH
AF:
0.115
GnomAD2 exomes
AF:
0.119
AC:
18384
AN:
154242
AF XY:
0.116
show subpopulations
Gnomad AFR exome
AF:
0.0905
Gnomad AMR exome
AF:
0.159
Gnomad ASJ exome
AF:
0.128
Gnomad EAS exome
AF:
0.334
Gnomad FIN exome
AF:
0.0807
Gnomad NFE exome
AF:
0.0832
Gnomad OTH exome
AF:
0.115
GnomAD4 exome
AF:
0.0947
AC:
129233
AN:
1364416
Hom.:
8006
Cov.:
27
AF XY:
0.0947
AC XY:
63904
AN XY:
675044
show subpopulations
African (AFR)
AF:
0.0910
AC:
2813
AN:
30898
American (AMR)
AF:
0.156
AC:
5573
AN:
35664
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
3216
AN:
24886
East Asian (EAS)
AF:
0.369
AC:
13097
AN:
35512
South Asian (SAS)
AF:
0.0964
AC:
7575
AN:
78562
European-Finnish (FIN)
AF:
0.0832
AC:
4073
AN:
48968
Middle Eastern (MID)
AF:
0.0991
AC:
544
AN:
5490
European-Non Finnish (NFE)
AF:
0.0824
AC:
86282
AN:
1047686
Other (OTH)
AF:
0.107
AC:
6060
AN:
56750
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
5651
11301
16952
22602
28253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3358
6716
10074
13432
16790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.102
AC:
15484
AN:
151832
Hom.:
977
Cov.:
31
AF XY:
0.103
AC XY:
7636
AN XY:
74170
show subpopulations
African (AFR)
AF:
0.0938
AC:
3887
AN:
41440
American (AMR)
AF:
0.133
AC:
2026
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.132
AC:
459
AN:
3472
East Asian (EAS)
AF:
0.337
AC:
1721
AN:
5102
South Asian (SAS)
AF:
0.111
AC:
533
AN:
4810
European-Finnish (FIN)
AF:
0.0818
AC:
862
AN:
10542
Middle Eastern (MID)
AF:
0.110
AC:
32
AN:
292
European-Non Finnish (NFE)
AF:
0.0836
AC:
5679
AN:
67898
Other (OTH)
AF:
0.115
AC:
243
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
698
1396
2093
2791
3489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0935
Hom.:
136
Bravo
AF:
0.108
Asia WGS
AF:
0.205
AC:
709
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Oct 07, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 15, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.96
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730880340; hg19: chr15-66679649; COSMIC: COSV61072417; COSMIC: COSV61072417; API